altRx vs Vaylen: Which compounded GLP-1 fits you best?
Quick verdict: altRx positions itself as the most affordable, no-commitment, buy-now-pay-later GLP-1 program with semaglutide from $89/month and 2-day delivery, while Vaylen advertises the lowest annualized semaglutide rate at $83.25/month on a prepaid 12-month plan and a needle-free oral option. Both use compounded medications and require clinician review.
Explore altRx pricing and start the 2-minute quiz
altRx vs Vaylen: the main differences at a glance
This comparison contrasts five distinguishing areas: pricing and billing structure, medication formats and options, refund and approval flow, delivery timing and enrollment model, and regulatory status. Each point uses only the supplied evidence.
| Criteria | altRx | Vaylen |
|---|---|---|
| Published starting price | $89/mo semaglutide; $149/mo tirzepatide | $83.25/mo semaglutide on 12-month plan; $224/mo month-to-month |
| Billing and commitment | Direct-pay monthly pricing, cancel anytime, buy now pay later options | Prepaid 12-month rates billed upfront; pay-first model with full refund if not approved |
| Medication formats | Compounded injected GLP-1 options (semaglutide, tirzepatide) | Compounded injectables and oral semaglutide tablets; injectable and tablet available |
| Clinician review and refund policy | Licensed provider reviews evaluation; no prepay required, treatment if appropriate | Clinician reviews after prepay; full refund for that billing cycle if clinician declines |
| Shipping and timing | Free, discreet 2-day delivery; typical processing 4–5 business days | Free discreet shipping in 1 to 3 business days; shipping after clinician review or fulfillment |
| Availability and certifications | Available in all 50 U.S. states; state-licensed 503A compounding pharmacies | Licensed in 50 states; LegitScript certified; licensed U.S. clinicians via OpenLoop Health |
| Regulatory note | Compounded medications are not FDA-approved | Compounded medications are not FDA-approved |
1. Pricing and billing structure
Both providers advertise low headline prices, but their billing models differ. altRx lists semaglutide from $89/month and tirzepatide from $149/month with month-to-month pricing, buy now, pay later options, and no membership or hidden fees. Vaylen advertises a lower annualized semaglutide rate at $83.25/month, but that headline rate requires prepaying a 12-month plan in a single charge. Vaylen also publishes higher month-to-month rates, for example $224/mo for semaglutide.
See Vaylen prepaid plans and pricing
2. Medication formats and clinical flexibility
Vaylen distinguishes itself by offering both injectable and oral semaglutide plus tirzepatide on one platform, so a clinician can switch a patient between formats without changing providers. altRx focuses on compounded semaglutide and tirzepatide supplied via its membership kits and clinician oversight. Both providers state medications are compounded.
Compare altRx treatment kits and support
3. Approval flow and refund policy
The approval and payment order differ. altRx uses a 2-minute quiz and 100% online medical visits; a licensed provider reviews your health evaluation and prescribes if appropriate, with no requirement to prepay before review. Vaylen requires customers to start the subscription and prepay a 12-month plan before clinician review, but offers a published full refund for that billing cycle if the clinician declines to prescribe.
4. Shipping, speed, and accessibility
altRx promotes free, discreet 2-day delivery with typical processing and delivery of about 4 to 5 business days and availability in all 50 states with state-licensed compounding pharmacies. Vaylen advertises free discreet shipping in 1 to 3 business days and also lists availability in all 50 states and clinician coverage via OpenLoop Health.
5. Regulatory and risk considerations
Both providers disclose that compounded medications are not FDA-approved finished products and have not been evaluated by the FDA for safety, effectiveness, or quality. altRx explicitly notes its medications are compounded by state-licensed 503A pharmacies. Vaylen states the same compounded status and adds LegitScript certification and HIPAA protection for its platform.
Which should you choose: altRx vs Vaylen
Choose altRx if you want a low headline monthly price without prepaying a year, prefer buy now, pay later options, and value a 100% online quiz and clinician review model with free 2-day delivery. Choose Vaylen if you are willing to prepay a 12-month plan to access the lowest annualized semaglutide rate, want an oral semaglutide option, and prefer a published full refund if a clinician declines to prescribe. Both use compounded medications and require clinician review.